David R. Gandara
Direttore/Membro del Consiglio presso International Association for the Study of Lung Cancer
Profilo
David R.
Gandara has been a Director of Response Genetics, Inc. since April 30, 2008 and Associate Director of Clinical Research and a Director of Thoracic Oncology for the University of California, Davis Cancer Center since 1994.
He is a Professor of Medicine for the University of California, Davis School of Medicine.
Dr. Gandara is a Director of International Association for the Study of Lung Cancer.
He was a Director, Secretary and Treasurer of the American Society for Clinical Oncology.
Dr. Gandara is Chairman of the NCI-directed Lung Correlative Science Committee.
He received an MD from the University of Texas Medical Branch and a BA from the University of Texas.
Posizioni attive di David R. Gandara
| Società | Posizione | Inizio |
|---|---|---|
| International Association for the Study of Lung Cancer | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di David R. Gandara
| Società | Posizione | Fine |
|---|---|---|
| RESPONSE GENETICS, INC | Direttore/Membro del Consiglio | 19/01/2010 |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Segretario Aziendale | - |
Formazione di David R. Gandara
| The University of Texas at Austin | Undergraduate Degree |
| University of Texas Medical Branch | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| RESPONSE GENETICS, INC | Health Technology |
| Aziende private | 2 |
|---|---|
| International Association for the Study of Lung Cancer | |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Health Services |
- Borsa valori
- Insiders
- David R. Gandara
